Ursprung des Netzwerks ersten Grades von Bjarne Bymose
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Valderm ApS
Valderm ApS Pharmaceuticals: MajorHealth Technology Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark.
4
| Extinct | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bjarne Bymose
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Chairman Director/Board Member | |
University of Copenhagen | College/University | Graduate Degree Graduate Degree | |
SEED Capital Management I/S
SEED Capital Management I/S Investment ManagersFinance SEED Capital Management I/S is an Independent Venture Capital firm founded in 2004. The company is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor | |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Biotechnology | President | |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Yamanouchi Nordic | Chief Tech/Sci/R&D Officer | ||
BOTANIX PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chairman | |
Dencore ApS
Dencore ApS Industrial MachineryProducer Manufacturing Dencore ApS is a holding company that manufactures packaging machines for the diagnostic, biotech, and pharmaceutical sectors. Its products include Microtube Filling and Capping Systems, Microtube Capping Systems, and Microtube Labelling Systems. It also offers IQ, OQ, and PQ documentation, installation and equipment training, and on site service and repair. The company was founded by Jens Agerskov in 2010 and is headquartered in Jyllinge, Denmark. | Industrial Machinery | Director/Board Member | |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Chairman | |
Medi Telecom SA
Medi Telecom SA Wireless TelecommunicationsCommunications Medi Telecom SA engages in the provision of wireless telecommunications services. The company was founded in 1999 and is headquartered in Casablanca, Morocco. | Wireless Telecommunications | Director/Board Member | |
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Corporate Officer/Principal | |
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Global Aviation Data A/S
Global Aviation Data A/S Electronic Equipment/InstrumentsElectronic Technology Global Aviation Data A/S develops system for managing the risk of overexposure to cosmic radiation during air transportation. Its system is designed to help frequent flyers and airlines to manage and minimize their risk of overexposure to radiation. The firm also handles the administrative and reporting procedures necessary to comply with existing and future national and international legislation and regulation concerning cosmic radiation. The company was founded by Peer Widar Wollenberg on July 4, 2003 and is headquartered in Klampenborg, Denmark. | Electronic Equipment/Instruments | Chairman | |
BluSense Diagnostics ApS
BluSense Diagnostics ApS Medical SpecialtiesHealth Technology BluSense Diagnostics ApS develops medical devices through connecting to cloud software. It offers BluBox, Viro-Track, and nanotechnology and microfluidics. The company was founded by Marco Donolato in 2014 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Chairman | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Founder | |
Evolva A/S | Director/Board Member | ||
Danske Private Equity A/S
Danske Private Equity A/S Investment ManagersFinance Danske Private Equity A/S (DPE) is a private equity fund of funds investment firm founded in 1999. The firm is headquartered in Lyngby. | Investment Managers | Corporate Officer/Principal | |
Statens Serum Institute | College/University | Doctorate Degree | |
Bok Holding A/S
Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Biotechnology | Director/Board Member | |
Technical University of Denmark | College/University | Graduate Degree | |
Copenhagen Business School | College/University | Undergraduate Degree | |
Ranger Biotechnologies A/S
Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
FluimediX ApS
FluimediX ApS Medical SpecialtiesHealth Technology FluimediX ApS provides diagnostic system capable of deoxyribonucleic acid based species determination. Its product, called NanoCycler, delivers an identification of the presence of patogen species, based on their unique DNA 'fingerprint'. The firm markets its product for the use of the dairy production industry. It also collaborates with others in the fields of engineering, microtechnology, and surface analysis. The company was founded by Tomas Ussing in 2003 and is headquartered in Taastrup, Denmark. | Medical Specialties | Chairman | |
CytoTrack ApS
CytoTrack ApS Electronic Equipment/InstrumentsElectronic Technology CytoTrack ApS engages in the provision of medical scanners for rare cell detection systems. Its products include CytoTrack CT11 scanner, CytoDisk and CytoCover, and CytoTrack reagent kit. The company was founded by Christian Caspersen, Tom Hede Markussen and Lars Ulrik Nielsen in 2004 and is headquartered in Lyngby, Denmark. | Electronic Equipment/Instruments | Chairman | |
OncoNOx ApS
OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Asiros A/S
Asiros A/S Agricultural Commodities/MillingProcess Industries Asiros A/S manufactures bioactive based food ingredients and formulation. Its products include BerryShield berry powders used to manufacture berry powders and MitoActive products are based on the discovery of a bioactive compound in certain varieties of red- and blackcurrants. The comapny was founded in 2007 and is headquartered in Copenhagen, Denmark. | Agricultural Commodities/Milling | Director/Board Member | |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | Pharmaceuticals: Major | Chairman | |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Contera Pharma ApS
Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Celltrix AB
Celltrix AB Medical SpecialtiesHealth Technology Celltrix AB manufactures medical devices. It develops novel and injectable dermal filler for reconstructive cosmetic surgery, based on microbeads of cross-linked gelatine. The company was founded in December 2003 by Kjell Gösta Conny Nilsson and is headquartered in Malmö, Sweden. | Medical Specialties | Director/Board Member | |
ACARIX AB | Medical Specialties | Director/Board Member | |
ALK-ABELLÓ A/S | Biotechnology | Corporate Officer/Principal | |
UV Clinical ApS
UV Clinical ApS SemiconductorsElectronic Technology UV Clinical ApS is a technology company, which engages in the development of devices using ultra-violet light emitting diodes for disinfection of medical implants. The company was founded by Leif Helth Jensen and Jimmy Bak and is headquartered in Greve, Denmark. | Semiconductors | Founder |
Statistik
International
Dänemark | 44 |
Schweden | 4 |
Australien | 2 |
Marokko | 2 |
Sektoral
Health Technology | 28 |
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 4 |
Electronic Technology | 4 |
Operativ
Director/Board Member | 32 |
Chairman | 10 |
Corporate Officer/Principal | 5 |
Graduate Degree | 3 |
Private Equity Investor | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Carsten Schou | 20 |
Leif Helth Jensen | 20 |
Ole Bitsch-Jensen | 13 |
Elisabeth de Darkó | 2 |
- Börse
- Insiders
- Bjarne Bymose
- Unternehmensverbindungen